Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach? Stefanie Desmet, Jan Verhaegen, Marc Van Ranst,

Slides:

Advertisements

Similar presentations

Speciation by symbiosis Robert M. Brucker, Seth R. Bordenstein Trends in Ecology & Evolution Volume 27, Issue 8, Pages (August 2012) DOI: /j.tree

Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010 Koh Cheng Thoon, Chia Yin Chong,

Pathogenesis of urinary tract infections with normal female anatomy

ZIKA App – A great resource from the World Health Organization (WHO)

Antimicrobial therapy to prevent or treat oral mucositis

Increase in sexually transmitted infections during Europride 2013 in Marseille, France Grégory Dubourg, Philippe Colson, Catherine Tamalet, Pierre Edouard.

Thank God for Richard Dawkins?

The benefits and harms of breast cancer screening

Lei Gao, Qi Jin The Lancet Infectious Diseases

Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study Dr.

Controlling Ebola: key role of Ebola treatment centres

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period J. Liñares, C. Ardanuy, R. Pallares, A.

Infections related to totally implantable venous-access ports

Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia

Herpes zoster in non-hospitalized children

Cervical cancer incidence can increase despite HPV vaccination

Underestimate of annual malaria imports to Canada – Author reply

Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era S. Nunes,

Political factors behind US global AIDS programmes slow-down

Klebsiella pneumoniae liver abscesses

When less is more: how many doses of PCV are enough?

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Constantly high incidence of scarlet fever in Germany

Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca N. Moustaoui,

Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine E. Calbo, Á. Díaz, E.

Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era S. Nunes,

Until eradication, awareness

Disease and stigma The Lancet Volume 354, (December 1999)

Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis Dr Tinevimbo.

HIV myths should not be resuscitated

Challenges to eliminate rabies virus infection in China by 2020

James E Scriven, David G Lalloo, Graeme Meintjes

Sofie Arens, Jan Verhaegen, Ludo Verbist

Effect of development assistance on domestic health expenditures

Modelling the effect of early detection of Ebola

Assessment of herd immunity from human papillomavirus vaccination

What would happen if we stopped vaccination?

Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes S. Ladhani,

Daniel M. Musher, MD Mayo Clinic Proceedings

Confessions of a journal junkie

Errata The Lancet Infectious Diseases

Sven Pischke, Patrick Behrendt, Michael P Manns, Heiner Wedemeyer

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort.

Telling it like it isn't: truth and lies in a post-9/11 world

Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989–2008) C. Esteva, L. Selva, M.F.

Availability of essential diagnostics in primary care in India

Thank God for Richard Dawkins?

Changes in Streptococcus pneumoniae serotypes causing invasive disease with non- universal vaccination coverage of the seven-valent conjugate vaccine

Low-technology approaches

Diagnosis of tuberculous meningitis with invasive pulmonary sampling

Thank you to our diverse (but not diverse enough) reviewers

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational.

Clinical Microbiology and Infection

Procalcitonin as a diagnostic marker for sepsis

The 2009 influenza pandemic

GBD 2016 estimates problematic for South Africa

Infections related to totally implantable venous-access ports

Children and adolescents with HIV

Stephen Allison, Tarun Bastiampillai, Doris A Fuller

Dengue pre-vaccination screening and positive predictive values

A remarkable report card on progress in COPD

Ebola control: rapid diagnostic testing

Political factors behind US global AIDS programmes slow-down

A 12 year outbreak of scarlet fever in Singapore

Tapestry of life The Lancet Volume 375, Issue 9723, (April 2010)

Volume 349, Issue 9062, Pages (May 1997)

Symptom-based stratification of autoimmune diseases

Sickle cell disease: a new era

Autism, maths, and sex: the special triangle

Presentation transcript:

Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach? Stefanie Desmet, Jan Verhaegen, Marc Van Ranst, Willy Peetermans, Katrien Lagrou The Lancet Infectious Diseases Volume 18, Issue 8, Pages 830-831 (August 2018) DOI: 10.1016/S1473-3099(18)30346-3 Copyright © 2018 Elsevier Ltd Terms and Conditions

Figure Evolution of the number of pneumococcal isolates (line) and serotype 19A isolates (columns) in Belgium causing invasive pneumococcal disease in children aged 0–2 years, 2006–17 The Lancet Infectious Diseases 2018 18, 830-831DOI: (10.1016/S1473-3099(18)30346-3) Copyright © 2018 Elsevier Ltd Terms and Conditions